Increased incidence of clostridium difficile PCR ribotype 027 in Hesse, Germany, 2011 to 2013

Eurosurveillance

Volumn 19, Issue 10, 2014, Pages

  Arvand, M ^a   Vollandt, D ^a   Bettge Weller, G ^a   Harmanus, C ^b   Kuijper, E J ^b  

^a Centre for Health Protection   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL VIRULENCE; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM DIFFICILE PCR RIBOTYPE 027; COMORBIDITY; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENERAL PRACTITIONER; GERMANY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MORBIDITY; MORTALITY; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; REHABILITATION CENTER; VERY ELDERLY;

CLOSTRIDIUM DIFFICILE; DISEASE NOTIFICATION; DISEASE OUTBREAKS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; INCIDENCE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RIBOTYPING;

EID: 84896272869     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.10.20732     Document Type: Article

References (25)

1. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-2449. http://dx.doi.org/10.1056/NEJMoa051639
2. McDonald LC, Killgore GE, Thompson A, Owens RC, Jr., Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-2441. http://dx.doi.org/10.1056/NEJMoa051590
3. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529-549. http://dx.doi.org/10.1128/CMR.00082-09
4. Kuijper EJ, Coignard B, Brazier JS, Suetens C, Drudy D, Wiuff C, et al. Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill. 2007;12(6):pii=714.
5. Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Infect. 2013;66(2):115-128. http://dx.doi.org/10.1016/j.jinf.2012.10.019
6. Kleinkauf N, Weiss B, Jansen A, Eckmanns T, Bornhofen B, Kuehnen E, et al. Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. Euro Surveill. 2007;12(46):pii=3307.
7. Reil M, Hensgens MP, Kuijper EJ, Jakobiak T, Gruber H, Kist M, et al. Seasonality of Clostridium difficile infections in Southern Germany. Epidemiol Infect. 2012;140(10):1787-1793. http://dx.doi.org/10.1017/S0950268811002627
8. Zaiss NH, Witte W, Nubel U. Fluoroquinolone resistance and Clostridium difficile, Germany. Emerg Infect Dis. 2010;16(4):675-677. http://dx.doi.org/10.3201/eid1604.090859
9. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73. http://dx.doi.org/10.1016/S0140-6736(10)61266-4
10. Robert Koch Institute. Schwer verlaufende Infektionen mit Clostridium difficile: Zur Meldepflicht. [Severe infections with Clostridium difficile: on mandatory reporting]. Epidemiologisches Bulletin. 2007;46:424. German. Available from: http://www.gpk.de/downloadp/STIKO_2007_Bulletin46_071116_Zunahme_von_Norovirus_Infektionen_koennte_erneute.pdf
11. Vonberg RP, Schwab F, Gastmeier P. Clostridium difficile in discharged inpatients, Germany. Emerg Infect Dis. 2007;13(1):179-180. http://dx.doi.org/10.3201/eid1301.060611
12. Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, et al. Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill. 2008;13(49):pii=19057.
13. Robert Koch Institute. Schwer verlaufende Clostridium-difficile-Infektionen: IfSG-Surveillancedaten von 2011 und 2012. [Severe infections with Clostridium difficile: surveillance data from 2011 and 2012]. Epidemiologisches Bulletin. 2013;25:233-237. German. Available from: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2013/Ausgaben/25_13.pdf?__blob=publicationFile
14. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G. Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill. 2009;14(45):pii=19403.
15. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G. [Epidemiology of severe Clostridium difficile infections in Hesse, Germany in 2008-2009]. Dtsch Med Wochenschr. 2010;135(40):1963-1967. http://dx.doi.org/10.1055/s-0030-1263342
16. Arvand M, Moser V, Schwehn C, Bettge-Weller G, Hensgens MP, Kuijper EJ. High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS ONE. 2012;7(1):e30183. http://dx.doi.org/10.1371/journal.pone.0030183
17. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett. 1999;175(2):261-266. http://dx.doi.org/10.1111/j.1574-6968.1999.tb13629.x
18. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056-1063. http://dx.doi.org/10.1093/cid/cis614
19. Brazier JS, Patel B, Pearson A. Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro Surveill. 2007;12(17):pii=3182.
20. Brazier JS, Raybould R, Patel B, Duckworth G, Pearson A, Charlett A, et al. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill. 2008;13(41):pii=19000.
21. Kuijper EJ, van den Berg RJ, Debast S, Visser CE, Veenendaal D, Troelstra A, et al. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis. 2006;12(5):827-830. http://dx.doi.org/10.3201/eid1205.051350
22. Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill. 2009;14(45):pii=19402.
23. Knetsch CW, Lawley TD, Hensgens MP, Corver J, Wilcox MW, Kuijper EJ. Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill. 2013;18(4):pii=20381.
24. Seventh annual report of the national reference laboratory for Clostridium difficile and results of the national surveillance, May 2012 to May 2013. Leiden: University Medical Center and Bilthoven: Center for Infectious Diseases Control; 2013. Available from:http://www.rivm.nl/dsresource?objectid=rivmp:211067&type=org&disposition=inline&ns_nc=1
25. KISS Krankenhaus-Infektions-Surveillance-System. Modul CDAD-KISS. Referenzdaten Berechnungszeitraum 1. Januar 2012 bis 31. Dezember 2012. [KISS hospital infection surveillance system. Module CDAD-KISS. Reference data evaluation period 1 January 2012 to 31 December 2012]. Berlin: Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen; 2013; German. Available from: http://www.nrz-hygiene.de/surveillance/kiss/cdad-kiss/da62c252/995/1365/